Navigation Links
Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
Date:9/12/2007

ACTON, Mass., Sept. 12 /PRNewswire-FirstCall/ -- Psychemedics Corporation (Amex: PMD) was selected to participate in and co-sponsor Chief Talent Officer, an innovative new book sponsored by Accenture that addresses human resource management issues and the growing imperative for HR leaders to become chief talent officers.

Chief Talent Officer showcases chief executive officers and human resource executives who have demonstrated innovative approaches to leading and managing human capital to drive high performance. The publication also presents insights on human capital and workforce performance from key senior executives within Accenture's Human Performance practice, other industry leaders and academia. The book describes a number of proven practices for strategic leadership of the HR function that executives can implement in their organizations today.

Ultimately, organizations that are leaders in managing talent have executives at their helms that elevate human performance initiatives to a strategic corporate platform. These chief talent officers are the driving forces that transform their organizations' workforces.

Chief Talent Officer profiles a number of leaders from companies including Sara Lee Corporation, Unilever, Royal Dutch Shell, AstraZeneca and AT&T that have "cracked the code" and adopted highly effective human capital management philosophies and practices that drive competitive advantage. Through specially commissioned interviews with these leaders, the book reveals best practices for strategic leadership of the HR function and demonstrates how successful chief talent officers have brought the workforce to the forefront of the executive agendas for their organizations.

Raymond C. Kubacki, Chairman and CEO of Psychemedics, is one of the leaders profiled in the book. "We work with HR executives every day of the week on how to reduce risk, including making sure that human assets don't become a liability," he states in the book. "We have a very large number of clients who are consistently addressing employee risk factors and understand how important those decisions are in creating a top-notch workforce and a positive workplace environment."

"Chief Talent Officer is very innovative," said Kubacki. "As HR executives undertake the journey to chief talent officers, the top human resource executive needs to become the chief talent officer and many companies are already in that mode to drive performance. Full implementation of this successful platform, however, is also dependent upon the CEO recognizing the significance of this CTO position and clearly establishing its importance within the whole organization."

The book will be distributed to CEO's and top HR professionals within Accenture's client organizations in the US and internationally. Total distribution will be 20,000.

About Psychemedics

Psychemedics is the world's largest provider of hair testing for drugs of abuse with thousands of corporations relying on the patented Psychemedics drug testing services. Psychemedics' clients include over 10% of the Fortune 500, some of the largest police departments in America and Federal Reserve Banks.

The Psychemedics web site is http://www.drugtestwithhair.com

Contact:

Raymond C. Kubacki

Chairman and CEO, Psychemedics Corporation

978-206-8220

Cautionary Statement for purposes of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995: From time to time, information provided by Psychemedics may contain forward-looking information that involves risks and uncertainties. In particular, statements contained in this release that are not historical facts (including but not limited to statements concerning growth, earnings, profit margins, earnings per share, revenues, dividends, future business, new accounts, customer base, market share, test volume and sales and marketing strategies) may be "forward looking" statements. Actual results may differ from those stated in any forward-looking statements. Factors that may cause such differences include but are not limited to risks associated with the expansion of the Company's sales and marketing network, development of markets for new products and services offered, the economic health of principal customers of the Company, government regulation, including but not limited to FDA regulations, competition and general economic conditions and other factors disclosed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Psychemedics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Rat joins list of cloned animals
4. Richard Gere Joins Indian Stars For Fight Against AIDS
5. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
6. Anoushka Joins Hands With WFP to Feed the Poor
7. India Joins Hands With Global Body for Vaccine Research
8. Another Statewide Organization Joins the Fight Against Assisted Suicide
9. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
10. Innovative device aids in advanced heart failure
11. Innovative footwear may prevent fall in elderly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... Women's Excellence specializes in pelvic conditions and has helped many women become ... Excellence uses a combination of office-based and simple outpatient evaluations. We can ...
(Date:4/26/2017)... ... ... RawTrition now brings you BioEnergy which is a powder capsule whole food ... RawTrition is taking nutrients to the next level! The superfoods in RawTrition's BioEnergy ... (unlike the synthetically made options that are on the market). , Founder of RawTrition, ...
(Date:4/26/2017)... ... 2017 , ... New SUPRO® XT55 Isolated Soy Protein ... helping beverage manufacturers more effectively manage protein costs. “Soy protein has always been ... as more stable pricing over time. Now it’s even more relevant as plant ...
(Date:4/26/2017)... ... 2017 , ... MYOLYN, a medical technology company dedicated to ... 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two of ... are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation (FES) ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... and collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 ... experience for education and business. , Mirroring360 Pro enables educators, business professionals and ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, Chile, ... their offering. ... Latin American pharmaceutical contract manufacturing services market is anticipated to ... registration cost in Latin American countries and continuous economic growth ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... The Global Effective Microorganisms (EM) Market by Manufacturers, ... and analysed the potential of Global Effective Microorganisms (EM) Market ... growth factors. The report identifies and analyses the emerging trends ... market. ... and Figures, 6 Major Company Profiles, spread across 124 pages ...
Breaking Medicine Technology: